Shares of Codexis Inc (CDXS) are trading -45% lower at a price of $6.665 at the time of this writing.

Codexis Inc has been trading between a 52-week high of $42.01 and a 52-week low of $6.615. The stock has a market cap of $435 Million.

Codexis is a leading enzyme engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis' proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.

Sunrun, 10x Genomics, Innovative Industrial Properties among premarket losers'' pack
Seeking Alpha 07-15-22

Why Codexis Shares Are Slumping Today
Benzinga 07-15-22

$32.9 Billion Worldwide Synthetic Biology Industry to 2027 - Featuring Amyris, Codexis and Danaher Among Others - ResearchAndMarkets.com
Business Wire 07-13-22

Is Codexis Inc. (NASDAQ:CDXS) stock a better investment at this time?
US Post News 07-04-22

Companies - Codexis, Inc. Given Consensus Rating of “Buy” by Brokerages
Business Mag 06-19-22